Rolph Timothy

CIK 00017794791 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001779479

Recent Transactions

50 trades

Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$28.35/sh+3,527→ 132,998 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$6.36/sh+43,064→ 176,062 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$21.09/sh+4,284→ 180,346 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$0.61/sh+2,796→ 183,142 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$0.61/sh+94,268→ 277,410 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$21.10/sh+4,739→ 282,149 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−2,796→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−94,268→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−43,064→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−4,284→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$28.35/sh+3,527→ 132,998 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$6.36/sh+43,064→ 176,062 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$21.09/sh+4,284→ 180,346 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$0.61/sh+2,796→ 183,142 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$0.61/sh+94,268→ 277,410 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$21.10/sh+4,739→ 282,149 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−2,796→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−94,268→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−43,064→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−4,284→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$28.35/sh+3,527→ 132,998 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$6.36/sh+43,064→ 176,062 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$21.09/sh+4,284→ 180,346 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$0.61/sh+2,796→ 183,142 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$0.61/sh+94,268→ 277,410 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$21.10/sh+4,739→ 282,149 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−2,796→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−94,268→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−43,064→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−4,284→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$28.35/sh+3,527→ 132,998 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$6.36/sh+43,064→ 176,062 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$21.09/sh+4,284→ 180,346 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$0.61/sh+2,796→ 183,142 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$0.61/sh+94,268→ 277,410 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$21.10/sh+4,739→ 282,149 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−2,796→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−94,268→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−43,064→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−4,284→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Stock Option (Right to Buy)
2025-11-25−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$28.35/sh+3,527→ 132,998 total
Exercise/Conversion
Akero Therapeutics, Inc.$AKRO
Common Stock
2025-11-25$6.36/sh+43,064→ 176,062 total

Companies

Akero Therapeutics, Inc.
Chief Scientific Officer
$AKRO

Recent Filings

4
Rolph Timothy
Nov 28, 2025

Address

601 GATEWAY BOULEVARD SUITE 350

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov